FIELD: pharmaceutics.
SUBSTANCE: invention refers to pyridine derivatives of formula (I)
having activity on S1P1/EDG1 receptor, pharmaceutical compositions based thereon, as well as to use of compounds for preparing pharmaceutical composition for preventing or treating diseases or disorders associated with activated immune system.
EFFECT: novel pyridine derivatives, as well as pharmaceutical compositions based thereon, which are suitable for treating diseases associated with activated immune system.
24 cl, 4 tbl, 69 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PYRIDIN-2-YL DERIVATIVES AS IMMUNOMODULATORY AGENTS | 2009 |
|
RU2494099C2 |
| PYRIMIDIN-4-YL DERIVATIVES | 2010 |
|
RU2547098C2 |
| PYRIDIN-3-YL DERIVATIVES AS IMMUNOMODULATORY AGENTS | 2007 |
|
RU2454413C2 |
| PHENYL DERIVATIVES AND THEIR APPLICATION AS IMMUNOMODULATORS | 2007 |
|
RU2442780C2 |
| NEW THIOPHENE DERIVATIVES AS S1P1/EDG1 RECEPTOR AGONISTS | 2007 |
|
RU2442783C2 |
| PYRIDIN-4-YL DERIVATIVES AS IMMUNOMODULATORY AGENTS | 2007 |
|
RU2447071C2 |
| NOVEL THIOPHENE DERIVATIVES AS S1P1/EDG1 RECEPTOR AGONISTS | 2007 |
|
RU2437877C2 |
| HETEROARYL COMPOUNDS AS TKB INHIBITORS AND USE THEREOF | 2015 |
|
RU2742122C2 |
| 2,6-SUBSTUTED-4-MONOSUBSTITUTED AMINO-PYRIMIDINES AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS | 2005 |
|
RU2417990C2 |
| HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND APPLICATION METHODS THEREOF | 2007 |
|
RU2435763C2 |
